The doctor behind a breakthrough New York City-based cancer study said that the astounding results are unlike anything he — or anyone — has seen before, as some of the patients who benefitted from the experimental drug spoke for the first time as well.
Four cancer survivors stood shoulder to shoulder with the two doctors credited with saving them. The patients — 19 in all, including six more that were included Monday and another one Tuesday — participated in a small clinical trial through Manhattan’s Memorial Sloan Kettering. Each had a specific form of rectal cancer, and took an experimental cancer drug called Dostarlimab.
Now, all of the 19
→ Continue reading at NBC New York
